HomeProductsBuilding BlocksHeterocyclic ScaffoldsThiophene CompoundsDuloxetine
Chemical structure of CAS 116539-59-4

Duloxetine

CAS No.116539-59-4
MDL No.MFCD06801358
MFC18H19NOS
MW297.40
InChI KeyZEUITGRIYCTCEM-KRWDZBQOSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

(S)-Duloxetine is an enantiomer of (R)-duloxetine.

CAS No.116539-59-4
Product NameDuloxetine

Biological Targets

SLC6A2·SLC6A4

Associated Conditions

multiple sclerosis·Chronic pain·Urinary incontinence·neuropathic pain·post-traumatic stress disorder·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Circling behavior induced by microinjection of serotonin reuptake inhibitors in the substantia nigra.

Pharmacology, biochemistry, and behavior • Vol. 71, Issue 1-2 • 2002
PMID: 11812544DOI: 10.1016/s0091-3057(01)00721-3

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

Pharmacology, biochemistry, and behavior • Vol. 71, Issue 4 • 2002
PMID: 11888558DOI: 10.1016/s0091-3057(01)00701-8

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

The Journal of clinical psychiatry • Vol. 63, Issue 3 • 2002
PMID: 11926722DOI: 10.4088/jcp.v63n0309

Somatic symptoms, depression, and antidepressant treatment.

The Journal of clinical psychiatry • Vol. 63, Issue 4 • 2002
PMID: 12000203DOI: 10.4088/jcp.v63n0406

Documentation

Similar Products